Commodities
Commented by Armin Schulz on January 5th, 2026 | 07:25 CET
Precious metals crash after margin shock – Operations continue at Barrick Mining, AJN Resources, and B2Gold
The sudden collapse of gold prices in the last week of December 2025 revealed the hidden levers of the financial markets. The trigger was not fundamental news, but a technical decision. The CME Group's increase in margin requirements forced highly leveraged speculators to sell, abruptly ending the spectacular rally. This forced liquidation reveals how stock market mechanisms can force abrupt corrections even in bullish markets. In this volatile phase, it is worth taking a look at established players and agile explorers. How are heavyweights Barrick Mining, explorer AJN Resources, and growth producer B2Gold positioning themselves for the coming year?
Read
Commented by Carsten Mainitz on January 2nd, 2026 | 07:20 CET
Correction in gold and silver? Margin calls? What this means for Kobo Resources, Barrick Mining, First Majestic, and the sector!
The bull market in precious metals came to an end in 2025 with prices close to all-time highs. Gold rose by around 65%, silver by around 150%. In the last days of last year, margin increases for metal futures on the CME, the world's largest futures exchange, led to a short-term correction in precious metal prices. US banks Goldman Sachs and JPMorgan remain bullish and expect gold prices to reach at least USD 4,900 this year. Experts identify interest rate cuts, strong physical demand, and purchases by central banks as the driving forces. These are good prospects for producers Barrick and First Majestic. Second-tier stocks such as Kobo Resources have recently outperformed blue chips and have a good chance of outperforming the market leaders this year.
Read
Commented by Fabian Lorenz on January 2nd, 2026 | 07:10 CET
BYD vs. Tesla! AI beneficiaries BioNTech and Rio Tinto partner Aspermont! Stocks for 2026?
A bombshell just before New Year's Eve! BYD has knocked Tesla off its electric vehicle throne. The Chinese company is now also the global market leader in purely electric vehicles. However, the stock clearly disappointed in 2025. One potential winner in 2026 could be Aspermont shares. The Company combines the booming commodities sector with a scalable technology business model in what is likely a unique way. The stock appears anything but expensive. BioNTech shareholders, on the other hand, had little to cheer about in 2025, as the stock lost almost 30% of its value. However, important study data is due in the current year. Analysts see a buying opportunity.
Read
Commented by Armin Schulz on December 30th, 2025 | 07:15 CET
Geopolitical flashpoint: Why Rio Tinto, Globex Mining, and BHP stand to benefit from trade wars
The global race for critical resources has entered an explosive phase. Driven by decarbonization and technological progress, structural shortages prevail. But now geopolitical power struggles are further heating up the situation: protectionist trade barriers and strategic control over supply chains are artificially reducing supply and catapulting the importance of independent producers into new spheres. In this environment, the strategies of commodity giants and emerging players are coming into sharp focus. Against this backdrop, it is worth taking a closer look at the positioning of Rio Tinto, Globex Mining, and BHP.
Read
Commented by Fabian Lorenz on December 30th, 2025 | 07:10 CET
Gold gem, AI fantasy, and pharmaceutical giant! Which stock will take off in 2026? TeamViewer, Novo Nordisk, Laurion Mineral Exploration
The gold rally is simply unstoppable. But the big producers such as Barrick Mining and Newmont have already run their course. However, there are always undiscovered gold gems to be found. LAURION Mineral Exploration is one of them. The management team made a convincing case at an investor conference, and the stock is unlikely to remain so cheap for long. Novo Nordisk staged a small year-end rally. Nevertheless, the slide in the share price during the current year has been painful. Can the stock pick up speed again in 2026? TeamViewer is one of the disappointments of 2025 in Germany. Will AI fantasy bring the German software company's stock back into an upward trend?
Read
Commented by Armin Schulz on December 30th, 2025 | 07:05 CET
Short squeeze alert in the silver market: First Majestic Silver, Silver Viper, and Pan American Silver in focus
Silver is experiencing an unprecedented rally. Driven by structural market shortages and massive industrial demand, the old price limits seem obsolete. This is especially true given the threat of a short squeeze, as some banks have built up short positions. But where does the sustainable potential lie? This development puts three players in particular in the spotlight: established producer First Majestic Silver, promising explorer Silver Viper, and industrial giant Pan American Silver.
Read
Commented by André Will-Laudien on December 29th, 2025 | 07:15 CET
Record year – Will 2026 be even better for BYD, Kobo Resources, Palantir, and DroneShield?
After an exceptionally strong 2025, investors are asking whether the rally can continue into 2026. Gold and silver reached new all-time highs at the turn of the year, and promising gold stocks such as Kobo Resources have gained more than 40% in recent weeks. Palantir Technologies, expensively valued but still widely recommended by analysts, has continued to reward shareholders. The V-shaped movement at DroneShield is also exciting, with its shares already doubling from their December sell-off lows. Meanwhile, BYD is entering a decisive phase as it accelerates its expansion strategy in Europe. What should investors focus on next?
Read
Commented by Fabian Lorenz on December 29th, 2025 | 07:00 CET
Comeback 2026! Tenfold potential? Evotec, Gerresheimer, and Desert Gold shares!
Looking for a potential ten-bagger in the gold sector? Analysts believe this could be possible for Desert Gold. The recently published PEA for the flagship gold project is triggering new price speculation. This could finally end the years-long sideways trend and allow the stock to take off. Investors had hoped for a turnaround in 2025 at Evotec. Instead, the biotech stock continued its downward trend. The strategy of the new management team does not appear to have convinced major shareholders either. Gerresheimer was an unpleasant surprise in 2025. At the turn of the year, the Company is at least engaged in damage control. But how significant is the loss of confidence?
Read
Commented by André Will-Laudien on December 29th, 2025 | 06:55 CET
The gold and silver frenzy continues! Barrick, RZOLV Technologies, First Majestic, and Endeavour Silver
Who would have thought? While much of the Christian world is celebrating a quiet Christmas, the precious metals market is booming. Gold has surged to USD 4,530, and silver, completely wild, has even broken through the USD 75 mark. Both metals are setting new all-time highs and displaying chart patterns not seen in years. Market participants are surprised by this sudden "knot bursting". Yet the reason seems obvious to many: for years, gold and silver prices were kept low in order to conceal the astronomical expansion of money supply and to cover up the underlying inflation. With returns now ranging from 70 to 140%, price increases are becoming evident that can only be explained by a long-overdue revaluation and an acute shortage of physical supply. Now it remains to be seen who can stay afloat in the flood. For mining companies and service providers, the time has come to close long-standing valuation gaps. We take a closer look.
Read
Commented by Fabian Lorenz on December 23rd, 2025 | 07:35 CET
Big news at the turn of the year! Nordex, Novo Nordisk, AJN Resources!
Is now the time for gold explorers? The price of gold remains firmly above USD 4,300 per ounce, and shares of gold producers are performing well, perhaps even a little too well. Investors looking to continue participating in the gold bull market may therefore turn their attention to exploration companies. One such candidate is AJN Resources. The stock has already moved higher, yet still offers upside potential, supported by takeover speculation. Novo Nordisk has submitted an application for US approval following convincing Phase 3 results, a step that would be strategically significant for the Company. Meanwhile, Nordex remains one of the positive surprises of 2025, having reported another major order. The key question now is how far can the rally go?
Read